Success of GeneProof SARS-CoV-2 in QCMD 04. 06. 2020
Both GeneProof PCR kits detecting SARS-CoV-2 successfully participated in QCMD panels. GeneProof SARS-CoV-2 PCR Kit and GeneProof SARS-CoV-2 Screening PCR Kit succeeded in the pool in the international External Quality Assesment panel.
What are the key points?
- GeneProof is one of the manufacturers who were 100% correct in all detections.
- Any kind of incorrect detection occurred with almost 20% of 521 datasets submitted.
- GeneProof PCR kits detected all samples, including those of 200 cp/ml concentration.
- Some of our competitors failed in more than 40% of 200 cp/ml cases.
- In-house methods failed in almost 18% of cases of 200 cp/ml cases.
- GeneProof detected all negative samples correctly as negative.
- Some competitors marked up to 10% of results as false-positive.
We are very proud of our PCR kits. You can see the our cummulative report below. Or see the individual reports here:
GeneProof SARS-CoV-2 PCR Kit: https://bit.ly/2U8BxM2
GeneProof SARS-CoV-2 Screening PCR Kit: https://bit.ly/36XUy93